Baxter International Inc. BAX
23.37
(0.11)
(0.47%)
as of 25 Sep
- Market cap
- $12.2B
- P/E
- 0.0×
Follow BAX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Baxter International Inc. (BAX) Gross margin
Baxter International Inc.'s gross margin over the twelve months to 30 June 2026 was 30.1%, up 0.0 percentage points from fiscal 2025 (30.1%). Over the past ten years it has ranged from 30.1% (fiscal 2025) to 42.9% (fiscal 2018) — the current reading is the lowest in ten years. That is below the Medical Instruments & Supplies industry median of 54.6% and below the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 30.1% | (7.41) |
| FY2024 | 37.5% | (2.60) |
| FY2023 | 40.1% | 4.77 |
| FY2022 | 35.3% | (3.57) |
| FY2021 | 38.9% | (0.44) |
| FY2020 | 39.3% | (2.60) |
| FY2019 | 41.9% | (0.98) |
| FY2018 | 42.9% | 0.61 |
| FY2017 | 42.3% | 1.77 |
| FY2016 | 40.5% | (1.09) |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 34.9% | 1.87 |
| Mar 2026 | 33.0% | 13.59 |
| Dec 2025 | 19.4% | (14.11) |
| Sep 2025 | 33.5% | (1.76) |
| 42 more quarters | Free account |
Against its own ten years
Low 30.1%
High 42.9%
Ten-year median
40.1%
Current reading's percentile
9
Gross margin against peers
| Company | Gross margin |
|---|---|
| ALGN Align Technology, Inc. compare | 68.1% |
| COO The Cooper Companies, Inc. compare | 65.9% |
| BLCO Bausch + Lomb Corporation compare | 61.4% |
| SOLV Solventum Corporation compare | 54.7% |
| RGEN Repligen Corporation compare | 53.5% |
| ATR AptarGroup, Inc. compare | 36.1% |
| AVTR Avantor, Inc. compare | 31.8% |
| BAX Baxter International Inc. | 30.1% |
| STVN Stevanato Group S.p.A. compare | 29.1% |
| Medical Instruments & Supplies industry median | 54.6% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on BAX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement